Heterologous protein incites abnormal plasma cell accumulation and autoimmunity in MRL-MpJ mice

Autoimmunity

Volumn 45, Issue 4, 2012, Pages 279-289

  McGaha, Tracy L ^a   Ma, Zhongjie ^b   Ravishankar, Buvana ^a   Gabunia, Khatuna ^b   McMenamin, Malgorzata ^a   Madaio, Michael P ^a  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

^b TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

autoantibody; Marginal zone B cell; MRL MpJ mice; systemic lupus erythematosus

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; AUTOIMMUNITY; B LYMPHOCYTE; CELL COUNT; CONTROLLED STUDY; FEMALE; GERMINAL CENTER; MOUSE; MOUSE STRAIN; MRL MPJ MOUSE; NONHUMAN; PLASMA CELL;

ANIMALS; ANTIBODIES, ANTINUCLEAR; AUTOIMMUNITY; DNA; FEMALE; GERMINAL CENTER; IMMUNOGLOBULIN G; LUPUS ERYTHEMATOSUS, SYSTEMIC; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, INBRED MRL LPR; PLASMA CELLS;

EID: 84859878279     PISSN: 08916934     EISSN: 1607842X     Source Type: Journal    
DOI: 10.3109/08916934.2012.654864     Document Type: Article

References (48)

1. Harley JB, Alarcon-Riquelme ME, Criswell LA, Jacob CO, Kimberly RP, Moser KL, Tsao BP, Vyse TJ, Langefeld CD, Nath SK, et al. Genome-wide association scan in women with systemic lupus erythematosus identifies susceptibility variants in ITGAM, PXK, KIAA1542 and other loci. Nat Genet 2008; 40:204-210. (Pubitemid 351171405)
2. Kozyrev SV, Abelson AK, Wojcik J, Zaghlool A, Linga Reddy MV, Sanchez E, Gunnarsson I, Svenungsson E, Sturfelt G, Jonsen A, et al. Functional variants in the B-cell gene BANK1 are associated with systemic lupus erythematosus. Nat Genet 2008;40:211-216. (Pubitemid 351171404)
3. Graham RR, Cotsapas C, Davies L, Hackett R, Lessard CJ, Leon JM, Burtt NP, Guiducci C, Parkin M, Gates C, et al. Genetic variants near TNFAIP3 on 6q23 are associated with systemic lupus erythematosus. Nat Genet 2008;40: 1059-1061.
4. Vas J, Monestier M. Immunology of mercury. Ann NY Acad Sci 2008;1143:240-267.
5. Satoh M, Kuroda Y, Yoshida H, Behney KM, Mizutani A, Akaogi J, Nacionales DC, Lorenson TD, Rosenbauer RJ, Reeves WH. Induction of lupus autoantibodies by adjuvants. J Autoimmun 2003;21:1-9. (Pubitemid 36871681)
6. Lee PY, Kumagai Y, Li Y, Takeuchi O, Yoshida H,Weinstein J, Kellner ES, Nacionales D, Barker T, Kelly-Scumpia K, et al. TLR7-dependent and FcgammaR-independent production of type I interferon in experimental mouse lupus. J Exp Med 2008;205:2995-3006.
7. Watson ML, Rao JK, Gilkeson GS, Ruiz P, Eicher EM, Pisetsky DS, Matsuzawa A, Rochelle JM, Seldin MF. Genetic analysis of MRL-lpr mice: relationship of the Fas apoptosis gene to disease manifestations and renal disease-modifying loci. J Exp Med 1992;176:1645-1656.
8. Gu L, Weinreb A, Wang XP, Zack DJ, Qiao JH, Weisbart R, Lusis AJ. Genetic determinants of autoimmune disease and coronary vasculitis in the MRL-lpr/lpr mouse model of systemic lupus erythematosus. J Immunol 1998;161: 6999-7006. (Pubitemid 28562249)
9. Vidal S, Kono DH, Theofilopoulos AN. Loci predisposing to autoimmunity in MRL-Fas lpr and C57BL/6-Faslpr mice. J Clin Invest 1998;101:696-702. (Pubitemid 28084255)
10. Pisetsky DS, Caster SA, Roths JB, Murphy ED. Ipr gene control of the anti-DNA antibody response. J Immunol 1982; 128:2322-2325. (Pubitemid 12086531)
11. Izui S, Kelley VE, Masuda K, Yoshida H, Roths JB, Murphy ED. Induction of various autoantibodies by mutant gene lpr in several strains of mice. J Immunol 1984;133: 227-233. (Pubitemid 14077907)
12. Bolland S, Yim YS, Tus K, Wakeland EK, Ravetch JV. Genetic modifiers of systemic lupus erythematosus in FcgammaRIIB(-/-) mice. J Exp Med 2002;195:1167-1174. (Pubitemid 34517142)
13. McGaha TL, Karlsson MC, Ravetch JV. FcgammaRIIB deficiency leads to autoimmunity and a defective response to apoptosis in Mrl-MpJ mice. J Immunol 2008;180:5670-5679.
14. Nijnik A, Ferry H, Lewis G, Rapsomaniki E, Leung JC, Daser A, Lambe T, Goodnow CC, Cornall RJ. Spontaneous B cell hyperactivity in autoimmune-prone MRL mice. Int Immunol 2006;18:1127-1137. (Pubitemid 43923430)
15. Rudolph EH, Congdon KL, Sackey FN, Fitzsimons MM, Foster MH. Humoral autoimmunity to basement membrane antigens is regulated in C57BL/6 and MRL/MpJ mice transgenic for anti-laminin Ig receptors. J Immunol 2002; 168:5943-5953. (Pubitemid 34556185)
16. Groom JR, Fletcher CA, Walters SN, Grey ST, Watt SV, Sweet MJ, Smyth MJ, Mackay CR, Mackay F. BAFF and MyD88 signals promote a lupuslike disease independent of T cells. J Exp Med 2007;204:1959-1971. (Pubitemid 47236330)
17. Tsao PY, Jiao J, Ji MQ, Cohen PL, Eisenberg RA. T cell-independent spontaneous loss of tolerance by anti-double-stranded DNA B cells in C57BL/6 mice. J Immunol 2008;181: 7770-7777.
18. Bolland S, Ravetch JV. Spontaneous autoimmune disease in Fc(gamma)RIIB-deficient mice results from strain-specific epistasis. Immunity 2000;13:277-285.
19. Hebert MJ, Takano T, Papayianni A, Rennke HG, Minto A, Salant DJ, Carroll MC, Brady HR. Acute nephrotoxic serum nephritis in complement knockout mice: relative roles of the classical and alternate pathways in neutrophil recruitment and proteinuria. Nephrol Dial Transplant 1998; 13:2799-2803. (Pubitemid 28479525)
20. Quigg RJ, He C, Lim A, BerthiaumeD, Alexander JJ, KrausD, Holers VM. Transgenic mice overexpressing the complement inhibitor crry as a soluble protein are protected from antibody-induced glomerular injury. J Exp Med 1998;188: 1321-1331. (Pubitemid 28478020)
21. Quigg RJ, Kozono Y, Berthiaume D, Lim A, Salant DJ, Weinfeld A, Griffin P, Kremmer E, Holers VM. Blockade of antibody-induced glomerulonephritis with Crry-Ig, a soluble murine complement inhibitor. J Immunol 1998;160: 4553-4560. (Pubitemid 28217315)
22. McGaha TL, Sorrentino B, Ravetch JV. Restoration of tolerance in lupus by targeted inhibitory receptor expression. Science 2005;307:590-593. (Pubitemid 40165683)
23. Meyers KE, Allen J, Gehret J, Jacobovits A, Gallo M, Neilson EG, Hopfer H, Kalluri R, Madaio MP. Human antiglomerular basement membrane autoantibody disease in XenoMouse II. Kidney Int 2002;61:166-173.
24. Lu TT, Cyster JG. Integrin-mediated long-term B cell retention in the splenic marginal zone. Science 2002;297: 409-412. (Pubitemid 34790772)
25. Furukawa F, Tanaka H, Sekita K, Nakamura T, Horiguchi Y, Hamashima Y. Dermatopathological studies on skin lesions of MRL mice. Arch Dermatol Res 1984;276:186-194. (Pubitemid 14107771)
26. Eisenberg R. Why can't we find a new treatment for SLE? J Autoimmun 2009;32:223-230.
27. Mohan C, Morel L, Yang P, Watanabe H, Croker B, Gilkeson G, Wakeland EK. Genetic dissection of lupus pathogenesis: a recipe for nephrophilic autoantibodies. J Clin Invest 1999; 103:1685-1695. (Pubitemid 29534363)
28. Morel L, Croker BP, Blenman KR, Mohan C, Huang G, Gilkeson G, Wakeland EK. Genetic reconstitution of systemic lupus erythematosus immunopathology with polycongenic murine strains. Proc Natl Acad Sci USA 2000;97: 6670-6675. (Pubitemid 30412772)
29. Unni KK, Holley KE, McDuffie FC, Titus JL. Comparative study of NZB mice under germfree and conventional conditions. J Rheumatol 1975;2:36-44.
30. Maldonado MA, Kakkanaiah V, MacDonald GC, Chen F, Reap EA, Balish E, Farkas WR, Jennette JC, Madaio MP, Kotzin BL, et al. The role of environmental antigens in the spontaneous development of autoimmunity in MRL-lpr mice. J Immunol 1999;162:6322-6330. (Pubitemid 29309350)
31. Klonowski KD, Monestier M. Heavy chain revision in MRL mice: a potential mechanism for the development of autoreactive B cell precursors. J Immunol 2000;165: 4487-4493.
32. Zemlin M, Ippolito GC, Zemlin C, Link J, Monestier M, Schroeder HW, Jr. Adult lupus-prone MRL/MpJ2 +mice express a primary antibody repertoire that differs in CDR-H3 length distribution and hydrophobicity from that expressed in the C3H parental strain. Mol Immunol 2005;42: 789-798. (Pubitemid 40489028)
33. Radic MZ, Mackle J, Erikson J, Mol C, Anderson WF, Weigert M. Residues that mediate DNA binding of autoimmune antibodies. J Immunol 1993;150:4966-4977. (Pubitemid 23150364)
34. Krishnan MR, Jou NT, Marion TN. Correlation between the amino acid position of arginine in VH-CDR3 and specificity for native DNA among autoimmune antibodies. J Immunol 1996;157:2430-2439. (Pubitemid 126450454)
35. Seal SN, Hoet RM, Raats JM, Radic MZ. Analysis of autoimmune bone marrow by antibody-phage display: somatic mutations and third complementarity- determining region arginines in anti-DNA gamma and kappa V genes. Arthritis Rheum 2000;43:2132-2138.
36. Seal SN, Monestier M, Radic MZ. Diverse roles for the third complementarity determining region of the heavy chain (H3) in the binding of immunoglobulin Fv fragments to DNA, nucleosomes and cardiolipin. Eur J Immunol 2000;30: 3432-3440. (Pubitemid 32005214)
37. Klonowski KD, Primiano LL, Monestier M. Atypical VH-D-JH rearrangements in newborn autoimmune MRL mice. J Immunol 1999;s162:1566-1572.
38. Chen C, Nagy Z, Prak EL, Weigert M. Immunoglobulin heavy chain gene replacement: a mechanism of receptor editing. Immunity 1995;3:747-755. (Pubitemid 26091148)
39. Brard F, Shannon M, Prak EL, Litwin S, Weigert M. Somatic mutation and light chain rearrangement generate autoimmunity in anti-single-stranded DNA transgenic MRL/lpr mice. J Exp Med 1999;190:691-704. (Pubitemid 29428651)
40. Rubio CF, Kench J, Russell DM, Yawger R, Nemazee D. Analysis of central B cell tolerance in autoimmune-prone MRL/lpr mice bearing autoantibody transgenes. J Immunol 1996;157:65-71. (Pubitemid 26190532)
41. Fatenejad S, Peng SL, Disorbo O, Craft J. Central T cell tolerance in lupus-prone mice: influence of autoimmune background and the lpr mutation. J Immunol 1998;161: 6427-6432. (Pubitemid 28536021)
42. Santiago-Raber ML, Amano H, Amano E, Fossati-Jimack L, Swee LK, Rolink A, Izui S. Evidence that Yaa-induced loss of marginal zone B cells is a result of dendritic cell-mediated enhanced activation. J Autoimmun 2010;34:349-355.
43. Xu H, Li H, Suri-Payer E, Hardy RR, Weigert M. Regulation of anti-DNA B cells in recombination-activating genedeficient mice. J Exp Med 1998;188:1247-1254. (Pubitemid 28478013)
44. Martin F, Kearney JF. Positive selection from newly formed to marginal zone B cells depends on the rate of clonal production, CD19, and btk. Immunity 2000;12:39-49. (Pubitemid 30069213)
45. Qian Y, Conway KL, Lu X, Seitz HM, Matsushima GK, Clarke SH. Autoreactive MZ and B-1 B-cell activation by Faslpr is coincident with an increased frequency of apoptotic lymphocytes and a defect in macrophage clearance. Blood 2006; 108:974-982. (Pubitemid 44154633)
46. Nimmerjahn F, Ravetch JV. Fc-receptors as regulators of immunity. Adv Immunol 2007;96:179-204. (Pubitemid 350018720)
47. Loh C, Pau E, Lajoie G, Li TT, Baglaenko Y, Cheung YH, Chang NH, Wither JE. Epistatic suppression of fatal autoimmunity in New Zealand black bicongenic mice. J Immunol 2011;186:5845-5853.
48. Arbuckle MR, McClain MT, Rubertone MV, Scofield RH, Dennis GJ, James JA, Harley JB. Development of autoantibodies before the clinical onset of systemic lupus erythematosus. N Engl J Med 2003;349:1526-1533. (Pubitemid 37255038)